1. Repository of OAI
  2. ΑΠΟΘΕΤΗΡΙΟ "ΟΛΥΜΠΙΑΣ"
  3. Σχολή Επιστημών Υγείας
  4. Τμήμα Ιατρικής
  5. Άρθρα σε επιστημονικά περιοδικά ( Ανοικτά) - ΙΑΤ
Ελληνικά   English  
Please use this identifier to cite or link to this item: https://olympias.lib.uoi.gr/jspui/handle/123456789/20071
Full metadata record
DC FieldValueLanguage
dc.contributor.authorProtopsaltis, I.en
dc.contributor.authorNikolopoulos, G.en
dc.contributor.authorDimou, E.en
dc.contributor.authorBrestas, P.en
dc.contributor.authorKokkoris, S.en
dc.contributor.authorKorantzopoulos, P.en
dc.contributor.authorMelidonis, A.en
dc.date.accessioned2015-11-24T19:04:36Z-
dc.date.available2015-11-24T19:04:36Z-
dc.identifier.issn1879-1484-
dc.identifier.urihttps://olympias.lib.uoi.gr/jspui/handle/123456789/20071-
dc.rightsDefault Licence-
dc.subjectAgeden
dc.subjectCoronary Disease/*complications/mortalityen
dc.subjectDiabetes Mellitus/metabolismen
dc.subjectDiabetes Mellitus, Type 2/*complications/mortalityen
dc.subjectFemaleen
dc.subjectHumansen
dc.subjectMaleen
dc.subjectMetabolic Syndrome X/*complications/mortalityen
dc.subjectMiddle Ageden
dc.subjectPredictive Value of Testsen
dc.subjectPrognosisen
dc.subjectRisken
dc.subjectTime Factorsen
dc.subjectTreatment Outcomeen
dc.titleMetabolic syndrome and its components as predictors of all-cause mortality and coronary heart disease in type 2 diabetic patientsen
heal.typejournalArticle-
heal.type.enJournal articleen
heal.type.elΆρθρο Περιοδικούel
heal.identifier.primary10.1016/j.atherosclerosis.2006.09.019-
heal.identifier.secondaryhttp://www.ncbi.nlm.nih.gov/pubmed/17064711-
heal.identifier.secondaryhttp://ac.els-cdn.com/S0021915006005910/1-s2.0-S0021915006005910-main.pdf?_tid=2602551c06dd589b57d88353362cf19f&acdnat=1333965354_c96546c2f43b26a62b05064b8258076a-
heal.languageen-
heal.accesscampus-
heal.recordProviderΠανεπιστήμιο Ιωαννίνων. Σχολή Επιστημών Υγείας. Τμήμα Ιατρικήςel
heal.publicationDate2007-
heal.abstractBACKGROUND: There is no consistent evidence regarding the prognostic value of metabolic syndrome (MS) in predicting all-cause mortality and coronary heart disease (CHD) risk among type 2 diabetic patients. We sought to investigate whether individual or various combinations of MS components have a different predictive value than the presence of MS in this setting. METHODS: Six hundred type 2 diabetic patients (mean age 60.4+/-9 years, 54% males) without known CHD were prospectively followed-up for a mean period of 10.06 years. The presence of MS was examined using the National Cholesterol Education Program (NCEP) definition. Statistical analyses were performed using Kaplan-Meier estimator and Cox proportional Hazard models. RESULTS: MS was present in 62.4% of the patients while 142 died during follow-up. Significant predictors for all-cause mortality were the presence of MS (HR 1.75), sex (HR 1.69), age (HR 1.09), and diabetes duration (HR 1.02). Regarding CHD incidents, HDL (HR 0.98), systolic blood pressure (HR 1.01), sex (HR 2.05), and total cholesterol (HR 1.005) were significant predictors while the presence of MS was not. Subjects fulfilling the triad consisting of diabetes, hypertension, and low HDL or the combination of diabetes, hypertension, low HDL, and high triglyceride levels had the highest probability for developing CHD events (HR 1.79, 1.73, respectively). CONCLUSIONS: The presence of MS in type 2 diabetic patients without known CHD reduces the 10-year survival while specific combinations of its components have different impact on CHD risk.en
heal.journalNameAtherosclerosisen
heal.journalTypepeer-reviewed-
heal.fullTextAvailabilityTRUE-
Appears in Collections:Άρθρα σε επιστημονικά περιοδικά ( Ανοικτά) - ΙΑΤ

Show simple item record
Files in This Item:
File Description SizeFormat 
Protopsaltis-2007-Metabolic syndrome a.pdf104 kBAdobe PDFView/Open    Request a copy
Show simple item record  


This item is licensed under a Creative Commons License Creative Commons